Global Helicobacter Pylori Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Helicobacter Pylori Diagnostics Market

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Diagnostics.

The Helicobacter Pylori Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Helicobacter Pylori Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Helicobacter Pylori Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Helicobacter Pylori Diagnostics Market Report

Chapter Outline

1.1 Helicobacter Pylori Diagnostics Product Introduction

1.2 Market by Type

1.2.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Invasive Techniques

1.2.3 Non-invasive Techniques

1.3 Market by Application

1.3.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Helicobacter Pylori Diagnostics Market Size Estimates and Forecasts

2.2 Helicobacter Pylori Diagnostics Market Size by Region: 2024 Versus 2031

2.2.1 Global Helicobacter Pylori Diagnostics Revenue by Region: 2020-2025

2.2.2 Global Helicobacter Pylori Diagnostics Revenue Forecast by Region (2026-2031)

2.2.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Region (2020-2031)

3.1 Breakdown Data by Type

3.1.1 Global Helicobacter Pylori Diagnostics Revenue by Type (2020-2031)

3.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Helicobacter Pylori Diagnostics Revenue by Application (2020-2031)

3.2.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Invasive Techniques of Helicobacter Pylori Diagnostics Revenue Market Share by Application

3.3.2 Non-invasive Techniques of Helicobacter Pylori Diagnostics Revenue Market Share by Application

4.1 Global Helicobacter Pylori Diagnostics Revenue by Company (2020-2025)

4.2 Global Helicobacter Pylori Diagnostics Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key Helicobacter Pylori Diagnostics Companies around the World: Ranking by Revenue

4.3.2 Global Helicobacter Pylori Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global Helicobacter Pylori Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global Helicobacter Pylori Diagnostics Companies Headquarters & Product Type

4.4.1 Global Helicobacter Pylori Diagnostics Companies Headquarters

4.4.2 Date of International Companies Enter into Helicobacter Pylori Diagnostics Market

4.4.3 Global Helicobacter Pylori Diagnostics Companies Product & Service

4.4.4 Invasive Techniques Revenue Market Share of Helicobacter Pylori Diagnostics by Company

4.4.5 Non-invasive Techniques Revenue Market Share of Helicobacter Pylori Diagnostics by Company

4.5 Global Helicobacter Pylori Diagnostics Mergers & Acquisitions, Expansion Plans

5.1 Sekisui Diagnostics

5.1.1 Sekisui Diagnostics Corporation Information

5.1.2 Sekisui Diagnostics Description, Business Overview

5.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Products Offered

5.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.1.5 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.1.6 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.1.7 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.1.8 Sekisui Diagnostics Recent Developments

5.2 F. Hoffmann-La Roche

5.2.1 F. Hoffmann-La Roche Corporation Information

5.2.2 F. Hoffmann-La Roche Description, Business Overview

5.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Products Offered

5.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.2.5 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.2.6 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.2.7 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.2.8 F. Hoffmann-La Roche Recent Developments

5.3 Medline Industries

5.3.1 Medline Industries Corporation Information

5.3.2 Medline Industries Description, Business Overview

5.3.3 Medline Industries Helicobacter Pylori Diagnostics Products Offered

5.3.4 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.3.5 Medline Industries Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.3.6 Medline Industries Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.3.7 Medline Industries Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.3.8 Medline Industries Recent Developments

5.4 Meridian Bioscience

5.4.1 Meridian Bioscience Corporation Information

5.4.2 Meridian Bioscience Description, Business Overview

5.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Products Offered

5.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.4.5 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.4.6 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.4.7 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.4.8 Meridian Bioscience Recent Developments

5.5 Bio-Rad Laboratories

5.5.1 Bio-Rad Laboratories Corporation Information

5.5.2 Bio-Rad Laboratories Description, Business Overview

5.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Products Offered

5.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.5.5 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.5.6 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.5.7 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.5.8 Bio-Rad Laboratories Recent Developments

5.6 Thermo Fisher Scientific

5.6.1 Thermo Fisher Scientific Corporation Information

5.6.2 Thermo Fisher Scientific Description, Business Overview

5.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Products Offered

5.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.6.5 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.6.6 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.6.7 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.6.8 Thermo Fisher Scientific Recent Developments

5.7 Alpha Laboratories

5.7.1 Alpha Laboratories Corporation Information

5.7.2 Alpha Laboratories Description, Business Overview

5.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Products Offered

5.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.7.5 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.7.6 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.7.7 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.7.8 Alpha Laboratories Recent Developments

5.8 EKF Diagnostics

5.8.1 EKF Diagnostics Corporation Information

5.8.2 EKF Diagnostics Description, Business Overview

5.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Products Offered

5.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.8.5 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.8.6 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.8.7 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.8.8 EKF Diagnostics Recent Developments

5.9 Quidel

5.9.1 Quidel Corporation Information

5.9.2 Quidel Description, Business Overview

5.9.3 Quidel Helicobacter Pylori Diagnostics Products Offered

5.9.4 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.9.5 Quidel Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.9.6 Quidel Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.9.7 Quidel Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.9.8 Quidel Recent Developments

5.10 Halyard Health

5.10.1 Halyard Health Corporation Information

5.10.2 Halyard Health Description, Business Overview

5.10.3 Halyard Health Helicobacter Pylori Diagnostics Products Offered

5.10.4 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.10.5 Halyard Health Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.10.6 Halyard Health Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.10.7 Halyard Health Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.10.8 Halyard Health Recent Developments

5.11 Cardinal Health

5.11.1 Cardinal Health Corporation Information

5.11.2 Cardinal Health Description, Business Overview

5.11.3 Cardinal Health Helicobacter Pylori Diagnostics Products Offered

5.11.4 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.11.5 Cardinal Health Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.11.6 Cardinal Health Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.11.7 Cardinal Health Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.11.8 Cardinal Health Recent Developments

5.12 Beckman Coulter

5.12.1 Beckman Coulter Corporation Information

5.12.2 Beckman Coulter Description, Business Overview

5.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Products Offered

5.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.12.5 Beckman Coulter Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.12.6 Beckman Coulter Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.12.7 Beckman Coulter Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.12.8 Beckman Coulter Recent Developments

5.13 Agilent Technologies

5.13.1 Agilent Technologies Corporation Information

5.13.2 Agilent Technologies Description, Business Overview

5.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Products Offered

5.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.13.5 Agilent Technologies Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.13.6 Agilent Technologies Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.13.7 Agilent Technologies Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.13.8 Agilent Technologies Recent Developments

5.14 Coris BioConcept

5.14.1 Coris BioConcept Corporation Information

5.14.2 Coris BioConcept Description, Business Overview

5.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Products Offered

5.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2020-2025)

5.14.5 Coris BioConcept Helicobacter Pylori Diagnostics Revenue by Product in 2024

5.14.6 Coris BioConcept Helicobacter Pylori Diagnostics Revenue by Application in 2024

5.14.7 Coris BioConcept Helicobacter Pylori Diagnostics Revenue by Geographic Area in 2024

5.14.8 Coris BioConcept Recent Developments

6.1 North America Helicobacter Pylori Diagnostics Market Size YoY Growth 2020-2031

6.2 North America Helicobacter Pylori Diagnostics Market Facts & Figures by Country (2020-2031)

6.3 North America Helicobacter Pylori Diagnostics Revenue by Type (2020-2025)

6.4 North America Helicobacter Pylori Diagnostics Revenue by Application (2020-2025)

7.1 Asia-Pacific Helicobacter Pylori Diagnostics Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Helicobacter Pylori Diagnostics Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Type (2020-2025)

7.4 Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Application (2020-2025)

8.1 Europe Helicobacter Pylori Diagnostics Market Size YoY Growth 2020-2031

8.2 Europe Helicobacter Pylori Diagnostics Market Facts & Figures by Country (2020-2031)

8.3 Europe Helicobacter Pylori Diagnostics Revenue by Type (2020-2025)

8.4 Europe Helicobacter Pylori Diagnostics Revenue by Application (2020-2025)

9.1 Latin America Helicobacter Pylori Diagnostics Market Size YoY Growth 2020-2031

9.2 Latin America Helicobacter Pylori Diagnostics Market Facts & Figures by Country (2020-2031)

9.3 Latin America Helicobacter Pylori Diagnostics Revenue by Type (2020-2025)

9.4 Latin America Helicobacter Pylori Diagnostics Revenue by Application (2020-2025)

10.1 Latin America Helicobacter Pylori Diagnostics Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Helicobacter Pylori Diagnostics Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Type (2020-2025)

10.4 Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Application (2020-2025)

11.1 Helicobacter Pylori Diagnostics Supply Chain Analysis

11.2 Helicobacter Pylori Diagnostics Key Raw Materials and Upstream Suppliers

11.3 Helicobacter Pylori Diagnostics Clients Analysis

11.4 Helicobacter Pylori Diagnostics Sales Channel and Sales Model Analysis

11.4.1 Helicobacter Pylori Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Helicobacter Pylori Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Helicobacter Pylori Diagnostics Distributors

12.1 Helicobacter Pylori Diagnostics Industry Trends

12.2 Helicobacter Pylori Diagnostics Market Drivers

12.3 Helicobacter Pylori Diagnostics Market Challenges

12.4 Helicobacter Pylori Diagnostics Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

List of Tables

 Table 1. Global Helicobacter Pylori Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Global Helicobacter Pylori Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

 Table 3. Global Helicobacter Pylori Diagnostics Market Size by Region (US$ Million): 2024 VS 2031

 Table 4. Global Helicobacter Pylori Diagnostics Revenue by Region (2020-2025) & (US$ Million)

 Table 5. Global Helicobacter Pylori Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)

 Table 6. Global Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 7. Global Helicobacter Pylori Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)

 Table 8. Global Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 9. Global Helicobacter Pylori Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)

 Table 10. Helicobacter Pylori Diagnostics Revenue by Company (2020-2025) & (US$ Million)

 Table 11. Helicobacter Pylori Diagnostics Revenue Share by Company (2020-2025)

 Table 12. Ranking of Global Top Helicobacter Pylori Diagnostics Players by Revenue (US$ Million) in 2024

 Table 13. Global Helicobacter Pylori Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

 Table 14. Global Helicobacter Pylori Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Diagnostics as of 2024)

 Table 15. Global Helicobacter Pylori Diagnostics Companies Headquarters

 Table 16. Date of International Companies Enter into Helicobacter Pylori Diagnostics Market

 Table 17. Global Helicobacter Pylori Diagnostics Companies Product & Service

 Table 18. Global Helicobacter Pylori Diagnostics Mergers & Acquisitions, Expansion Plans

 Table 19. Sekisui Diagnostics Corporation Information

 Table 20. Sekisui Diagnostics Description and Business Overview

 Table 21. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product

 Table 22. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 23. Sekisui Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 24. Sekisui Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 25. Sekisui Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 26. Sekisui Diagnostics Recent Developments

 Table 27. F. Hoffmann-La Roche Corporation Information

 Table 28. F. Hoffmann-La Roche Description and Business Overview

 Table 29. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product

 Table 30. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 31. F. Hoffmann-La Roche Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 32. F. Hoffmann-La Roche Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 33. F. Hoffmann-La Roche Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 34. F. Hoffmann-La Roche Recent Developments

 Table 35. Medline Industries Corporation Information

 Table 36. Medline Industries Description and Business Overview

 Table 37. Medline Industries Helicobacter Pylori Diagnostics Product

 Table 38. Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 39. Medline Industries Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 40. Medline Industries Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 41. Medline Industries Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 42. Medline Industries Recent Developments

 Table 43. Meridian Bioscience Corporation Information

 Table 44. Meridian Bioscience Description and Business Overview

 Table 45. Meridian Bioscience Helicobacter Pylori Diagnostics Product

 Table 46. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 47. Meridian Bioscience Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 48. Meridian Bioscience Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 49. Meridian Bioscience Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 50. Meridian Bioscience Recent Developments

 Table 51. Bio-Rad Laboratories Corporation Information

 Table 52. Bio-Rad Laboratories Description and Business Overview

 Table 53. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product

 Table 54. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 55. Bio-Rad Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 56. Bio-Rad Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 57. Bio-Rad Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 58. Bio-Rad Laboratories Recent Developments

 Table 59. Thermo Fisher Scientific Corporation Information

 Table 60. Thermo Fisher Scientific Description and Business Overview

 Table 61. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product

 Table 62. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 63. Thermo Fisher Scientific Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 64. Thermo Fisher Scientific Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 65. Thermo Fisher Scientific Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 66. Thermo Fisher Scientific Recent Developments

 Table 67. Alpha Laboratories Corporation Information

 Table 68. Alpha Laboratories Description and Business Overview

 Table 69. Alpha Laboratories Helicobacter Pylori Diagnostics Product

 Table 70. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 71. Alpha Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 72. Alpha Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 73. Alpha Laboratories Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 74. Alpha Laboratories Recent Developments

 Table 75. EKF Diagnostics Corporation Information

 Table 76. EKF Diagnostics Description and Business Overview

 Table 77. EKF Diagnostics Helicobacter Pylori Diagnostics Product

 Table 78. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 79. EKF Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 80. EKF Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 81. EKF Diagnostics Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 82. EKF Diagnostics Recent Developments

 Table 83. Quidel Corporation Information

 Table 84. Quidel Description and Business Overview

 Table 85. Quidel Helicobacter Pylori Diagnostics Product

 Table 86. Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 87. Quidel Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 88. Quidel Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 89. Quidel Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 90. Quidel Recent Developments

 Table 91. Halyard Health Corporation Information

 Table 92. Halyard Health Description and Business Overview

 Table 93. Halyard Health Helicobacter Pylori Diagnostics Product

 Table 94. Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 95. Halyard Health Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 96. Halyard Health Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 97. Halyard Health Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 98. Halyard Health Recent Developments

 Table 99. Cardinal Health Corporation Information

 Table 100. Cardinal Health Description and Business Overview

 Table 101. Cardinal Health Helicobacter Pylori Diagnostics Product

 Table 102. Cardinal Health Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 103. Cardinal Health Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 104. Cardinal Health Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 105. Cardinal Health Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 106. Cardinal Health Recent Developments

 Table 107. Beckman Coulter Corporation Information

 Table 108. Beckman Coulter Description and Business Overview

 Table 109. Beckman Coulter Helicobacter Pylori Diagnostics Product

 Table 110. Beckman Coulter Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 111. Beckman Coulter Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 112. Beckman Coulter Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 113. Beckman Coulter Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 114. Beckman Coulter Recent Developments

 Table 115. Agilent Technologies Corporation Information

 Table 116. Agilent Technologies Description and Business Overview

 Table 117. Agilent Technologies Helicobacter Pylori Diagnostics Product

 Table 118. Agilent Technologies Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 119. Agilent Technologies Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 120. Agilent Technologies Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 121. Agilent Technologies Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 122. Agilent Technologies Recent Developments

 Table 123. Coris BioConcept Corporation Information

 Table 124. Coris BioConcept Description and Business Overview

 Table 125. Coris BioConcept Helicobacter Pylori Diagnostics Product

 Table 126. Coris BioConcept Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

 Table 127. Coris BioConcept Revenue Proportion of Helicobacter Pylori Diagnostics by Product in 2024

 Table 128. Coris BioConcept Revenue Proportion of Helicobacter Pylori Diagnostics by Application in 2024

 Table 129. Coris BioConcept Revenue Proportion of Helicobacter Pylori Diagnostics by Geographic Area in 2024

 Table 130. Coris BioConcept Recent Developments

 Table 131. North America Helicobacter Pylori Diagnostics Revenue by Country (2020-2025) & (US$ Million)

 Table 132. North America Helicobacter Pylori Diagnostics Revenue by Country (2026-2031) & (US$ Million)

 Table 133. North America Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 134. North America Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 135. Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Region (2020-2025) & (US$ Million)

 Table 136. Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Region (2026-2031) & (US$ Million)

 Table 137. Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 138. Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 139. Europe Helicobacter Pylori Diagnostics Revenue by Country (2020-2025) & (US$ Million)

 Table 140. Europe Helicobacter Pylori Diagnostics Revenue by Country (2026-2031) & (US$ Million)

 Table 141. Europe Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 142. Europe Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 143. Latin America Helicobacter Pylori Diagnostics Revenue by Country (2020-2025) & (US$ Million)

 Table 144. Latin America Helicobacter Pylori Diagnostics Revenue by Country (2026-2031) & (US$ Million)

 Table 145. Latin America Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 146. Latin America Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 147. Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Country (2020-2025) & (US$ Million)

 Table 148. Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Country (2026-2031) & (US$ Million)

 Table 149. Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Type (2020-2025) & (US$ Million)

 Table 150. Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Application (2020-2025) & (US$ Million)

 Table 151. Helicobacter Pylori Diagnostics Key Raw Materials, Industry Status and Trend

 Table 152. Helicobacter Pylori Diagnostics Key Raw Materials and Upstream Suppliers

 Table 153. Helicobacter Pylori Diagnostics Clients Status and Trend

 Table 154. Helicobacter Pylori Diagnostics Typical Clients

 Table 155. Helicobacter Pylori Diagnostics Distributors

 Table 156. Helicobacter Pylori Diagnostics Market Trends

 Table 157. Helicobacter Pylori Diagnostics Market Drivers

 Table 158. Helicobacter Pylori Diagnostics Market Challenges

 Table 159. Helicobacter Pylori Diagnostics Market Restraints

 Table 160. Research Programs/Design for This Report

 Table 161. Key Data Information from Secondary Sources

 Table 162. Key Data Information from Primary Sources

List of Figures

 Figure 1. Helicobacter Pylori Diagnostics Product Picture

 Figure 2. Global Helicobacter Pylori Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

 Figure 3. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type in 2024 & 2031

 Figure 4. Invasive Techniques Product Picture

 Figure 5. Non-invasive Techniques Product Picture

 Figure 6. Global Helicobacter Pylori Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

 Figure 7. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application in 2024 & 2031

 Figure 8. Hospitals and Clinics

 Figure 9. Diagnostic Laboratories

 Figure 10. Others

 Figure 11. Helicobacter Pylori Diagnostics Report Years Considered

 Figure 12. Global Helicobacter Pylori Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 13. Global Helicobacter Pylori Diagnostics Market Size (2020-2031) & (US$ Million)

 Figure 14. Global Helicobacter Pylori Diagnostics Market Size Market Share by Region: 2024 Versus 2031

 Figure 15. Global Helicobacter Pylori Diagnostics Revenue Market Share by Region (2020-2031)

 Figure 16. Global Helicobacter Pylori Diagnostics Revenue Market Share Forecast by Type (2020-2031)

 Figure 17. Global Helicobacter Pylori Diagnostics Revenue Market Share Forecast by Application (2020-2031)

 Figure 18. Invasive Techniques of Helicobacter Pylori Diagnostics Revenue Market Share by Application, 2024 VS 2031

 Figure 19. Non-invasive Techniques of Helicobacter Pylori Diagnostics Revenue Market Share by Application, 2024 VS 2031

 Figure 20. Helicobacter Pylori Diagnostics Revenue Share by Company (2024)

 Figure 21. Helicobacter Pylori Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 22. Invasive Techniques Revenue Proportion by Company in 2024

 Figure 23. Non-invasive Techniques Revenue Proportion by Company in 2024

 Figure 24. North America Helicobacter Pylori Diagnostics Revenue 2020-2031 (US$ Million)

 Figure 25. North America Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2025)

 Figure 26. North America Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2025)

 Figure 27. Asia-Pacific Helicobacter Pylori Diagnostics Revenue 2020-2031 (US$ Million)

 Figure 28. Asia-Pacific Helicobacter Pylori Diagnostics Revenue Market Share by Region (2020-2031)

 Figure 29. Asia-Pacific Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2025)

 Figure 30. Asia-Pacific Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2025)

 Figure 31. Europe Helicobacter Pylori Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

 Figure 32. Europe Helicobacter Pylori Diagnostics Revenue Market Share by Country (2020-2031)

 Figure 33. Europe Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2025)

 Figure 34. Europe Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2025)

 Figure 35. Latin America Helicobacter Pylori Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

 Figure 36. Latin America Helicobacter Pylori Diagnostics Revenue Market Share by Country (2020-2031)

 Figure 37. Latin America Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2025)

 Figure 38. Latin America Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2025)

 Figure 39. Middle East and Africa Helicobacter Pylori Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

 Figure 40. Middle East and Africa Helicobacter Pylori Diagnostics Revenue Market Share by Country (2020-2031)

 Figure 41. Middle East and Africa Helicobacter Pylori Diagnostics Revenue Market Share by Type (2020-2025)

 Figure 42. Middle East and Africa Helicobacter Pylori Diagnostics Revenue Market Share by Application (2020-2025)

 Figure 43. Helicobacter Pylori Diagnostics Supply Chain (Upstream and Downstream Market)

 Figure 44. Global Production Market Share of Helicobacter Pylori Diagnostics Raw Materials by Region in 2024

 Figure 45. Helicobacter Pylori Diagnostics Distribution Channels

 Figure 46. Global Helicobacter Pylori Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales

 Figure 47. Global Helicobacter Pylori Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales

 Figure 48. Bottom-up and Top-down Approaches for This Report

 Figure 49. Data Triangulation

 Figure 50. Key Executives Interviewed